| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $187,316 | 7 | 100 |
Sells | $0 | 0 | 0 |
| BRADLEY WILLIAM | director | 2 | $90,232 | 0 | $0 | $90,232 |
| Rajagopalan Harith | Chief Executive Officer | 2 | $38,251 | 0 | $0 | $38,251 |
| Sheffield Ian | director | 1 | $25,529 | 0 | $0 | $25,529 |
| Royan Ajay | director | 1 | $19,596 | 0 | $0 | $19,596 |
| Smith Weber Lara | Chief Financial Officer | 1 | $13,708 | 0 | $0 | $13,708 |
Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering …
Over the last 12 months, insiders at Fractyl Health, Inc. have bought $187,316 and sold $0 worth of Fractyl Health, Inc. stock.
On average, over the past 5 years, insiders at Fractyl Health, Inc. have bought $2.59M and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: BRADLEY WILLIAM (director) — $90,232. Rajagopalan Harith (Chief Executive Officer) — $38,251. Sheffield Ian (director) — $25,529.
The last purchase of 64,516 shares for transaction amount of $39,903 was made by BRADLEY WILLIAM (director) on 2026‑09‑14.
| 2026-09-14 | BRADLEY WILLIAM | director | 64,516 0.0411% | $0.62 | $39,903 | -39.85% | ||
| 2026-06-12 | Royan Ajay | director | 23,000 0.0319% | $0.85 | $19,596 | -19.41% | ||
| 2026-06-10 | Rajagopalan Harith | Chief Executive Officer | 25,000 0.0345% | $0.73 | $18,253 | -6.38% | ||
| 2026-06-10 | BRADLEY WILLIAM | director | 68,493 0.0953% | $0.73 | $50,329 | -6.38% | ||
| 2026-06-10 | Sheffield Ian | director | 35,000 0.0483% | $0.73 | $25,529 | -6.38% | ||
| 2026-06-08 | Smith Weber Lara | Chief Financial Officer | 20,000 0.0283% | $0.69 | $13,708 | +2.24% | ||
| 2025-12-04 | Rajagopalan Harith | Chief Executive Officer | 10,416 0.0136% | $1.92 | $19,999 | -65.40% | ||
| 2024-02-06 | CVF, LLC | 10 percent owner | 333,333 3.4012% | $15.00 | $5M | -67.50% |
| Rajagopalan Harith | Chief Executive Officer | 540557 4.0751% | $485,528.30 | 2 | 0 | |
| BRADLEY WILLIAM | director | 149138 1.1243% | $133,955.75 | 2 | 0 | |
| Royan Ajay | director | 40901 0.3083% | $36,737.28 | 1 | 0 | |
| Sheffield Ian | director | 35000 0.2639% | $31,437.00 | 1 | 0 | |
| Smith Weber Lara | Chief Financial Officer | 20000 0.1508% | $17,964.00 | 1 | 0 | |
| CVF, LLC | 10 percent owner | 4673870 35.2346% | $4.2M | 1 | 0 | <0.0001% |
$18,815,063 | 62 | -6.45% | $13.7M | |
$1,993,425 | 46 | -21.91% | $13.95M | |
$95,567,744 | 39 | -17.01% | $10.94M | |
$30,257,839 | 29 | -15.72% | $12M | |
$76,600 | 22 | -38.58% | $10.49M |
| Increased Positions | 65 | +92.86% | 38M | +41.52% |
| Decreased Positions | 28 | -40% | 16M | -17.76% |
| New Positions | 33 | New | 15M | New |
| Sold Out Positions | 8 | Sold Out | 702,123 | Sold Out |
| Total Postitions | 107 | +52.86% | 112M | +23.76% |